nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanidine—SLC22A1—hematologic cancer	0.216	1	CbGaD
Guanidine—SLC22A3—Melphalan—hematologic cancer	0.0756	0.213	CbGbCtD
Guanidine—SLC22A2—Daunorubicin—hematologic cancer	0.0317	0.089	CbGbCtD
Guanidine—SLC22A2—Cytarabine—hematologic cancer	0.0279	0.0785	CbGbCtD
Guanidine—SLC22A2—Cladribine—hematologic cancer	0.0264	0.0741	CbGbCtD
Guanidine—SLC22A3—Irinotecan—hematologic cancer	0.0256	0.0719	CbGbCtD
Guanidine—SLC22A1—Cytarabine—hematologic cancer	0.0243	0.0682	CbGbCtD
Guanidine—SLC22A2—Imatinib—hematologic cancer	0.0243	0.0682	CbGbCtD
Guanidine—SLC22A1—Cladribine—hematologic cancer	0.0229	0.0644	CbGbCtD
Guanidine—SLC22A3—Vincristine—hematologic cancer	0.0224	0.0629	CbGbCtD
Guanidine—SLC22A1—Imatinib—hematologic cancer	0.0211	0.0592	CbGbCtD
Guanidine—SLC22A8—Mercaptopurine—hematologic cancer	0.021	0.0591	CbGbCtD
Guanidine—SLC22A2—Vinblastine—hematologic cancer	0.0135	0.0379	CbGbCtD
Guanidine—SLC22A2—Cisplatin—hematologic cancer	0.0124	0.0347	CbGbCtD
Guanidine—SLC22A8—Methotrexate—hematologic cancer	0.00688	0.0193	CbGbCtD
Guanidine—KCNH1—hematopoietic system—hematologic cancer	0.00322	0.0317	CbGeAlD
Guanidine—KCNG3—hematopoietic system—hematologic cancer	0.00322	0.0317	CbGeAlD
Guanidine—KCNA10—lung—hematologic cancer	0.00291	0.0286	CbGeAlD
Guanidine—KCNG2—testis—hematologic cancer	0.00274	0.027	CbGeAlD
Guanidine—KCNA3—hematopoietic system—hematologic cancer	0.00263	0.0259	CbGeAlD
Guanidine—KCNA2—hematopoietic system—hematologic cancer	0.0025	0.0246	CbGeAlD
Guanidine—KCNG3—blood—hematologic cancer	0.00214	0.021	CbGeAlD
Guanidine—KCNH3—blood—hematologic cancer	0.0019	0.0187	CbGeAlD
Guanidine—KCNV2—testis—hematologic cancer	0.00185	0.0182	CbGeAlD
Guanidine—KCNH8—blood—hematologic cancer	0.00184	0.0181	CbGeAlD
Guanidine—KCND1—gonad—hematologic cancer	0.00182	0.0179	CbGeAlD
Guanidine—KCNH1—testis—hematologic cancer	0.00177	0.0174	CbGeAlD
Guanidine—KCNA3—blood—hematologic cancer	0.00174	0.0171	CbGeAlD
Guanidine—GAMT—hematopoietic system—hematologic cancer	0.00169	0.0167	CbGeAlD
Guanidine—KCNA2—blood—hematologic cancer	0.00166	0.0163	CbGeAlD
Guanidine—KCNS1—blood—hematologic cancer	0.00166	0.0163	CbGeAlD
Guanidine—KCND1—blood—hematologic cancer	0.00158	0.0156	CbGeAlD
Guanidine—KCNG1—testis—hematologic cancer	0.00157	0.0155	CbGeAlD
Guanidine—KCNH3—testis—hematologic cancer	0.00157	0.0155	CbGeAlD
Guanidine—KCNA3—lung—hematologic cancer	0.00153	0.015	CbGeAlD
Guanidine—KCNH8—testis—hematologic cancer	0.00153	0.015	CbGeAlD
Guanidine—KCNC3—testis—hematologic cancer	0.00148	0.0146	CbGeAlD
Guanidine—KCNA5—gonad—hematologic cancer	0.00139	0.0137	CbGeAlD
Guanidine—KCND1—lung—hematologic cancer	0.00139	0.0137	CbGeAlD
Guanidine—KCNC4—lung—hematologic cancer	0.00139	0.0137	CbGeAlD
Guanidine—DLG4—testis—hematologic cancer	0.00137	0.0135	CbGeAlD
Guanidine—KCNS1—testis—hematologic cancer	0.00137	0.0135	CbGeAlD
Guanidine—KCNA2—testis—hematologic cancer	0.00137	0.0135	CbGeAlD
Guanidine—KCNF1—blood—hematologic cancer	0.00136	0.0133	CbGeAlD
Guanidine—KCND1—testis—hematologic cancer	0.00131	0.0129	CbGeAlD
Guanidine—KCNC4—testis—hematologic cancer	0.00131	0.0129	CbGeAlD
Guanidine—KCNC1—testis—hematologic cancer	0.00126	0.0124	CbGeAlD
Guanidine—KCNH7—testis—hematologic cancer	0.00126	0.0124	CbGeAlD
Guanidine—KCNQ4—testis—hematologic cancer	0.00126	0.0124	CbGeAlD
Guanidine—KCNQ2—gonad—hematologic cancer	0.00125	0.0123	CbGeAlD
Guanidine—KCNF1—lung—hematologic cancer	0.00119	0.0117	CbGeAlD
Guanidine—RNASE1—blood—hematologic cancer	0.00115	0.0113	CbGeAlD
Guanidine—RNASE1—bone marrow—hematologic cancer	0.00112	0.011	CbGeAlD
Guanidine—KCNA5—lung—hematologic cancer	0.00106	0.0105	CbGeAlD
Guanidine—KCNA3—lymph node—hematologic cancer	0.00104	0.0103	CbGeAlD
Guanidine—KCNS3—lung—hematologic cancer	0.00104	0.0102	CbGeAlD
Guanidine—KCNQ3—lung—hematologic cancer	0.00104	0.0102	CbGeAlD
Guanidine—RNASE1—lung—hematologic cancer	0.00101	0.00995	CbGeAlD
Guanidine—KCNA5—testis—hematologic cancer	0.001	0.00987	CbGeAlD
Guanidine—KCNA2—lymph node—hematologic cancer	0.000993	0.00977	CbGeAlD
Guanidine—DLG4—lymph node—hematologic cancer	0.000993	0.00977	CbGeAlD
Guanidine—KCNS3—testis—hematologic cancer	0.000983	0.00967	CbGeAlD
Guanidine—GAMT—Podofilox—Teniposide—hematologic cancer	0.000971	0.22	CbGdCrCtD
Guanidine—RNASE1—testis—hematologic cancer	0.000954	0.00938	CbGeAlD
Guanidine—KCNH6—lung—hematologic cancer	0.000951	0.00935	CbGeAlD
Guanidine—KCNC4—lymph node—hematologic cancer	0.00095	0.00934	CbGeAlD
Guanidine—GAMT—testis—hematologic cancer	0.000928	0.00913	CbGeAlD
Guanidine—ALDH2—hematopoietic system—hematologic cancer	0.00092	0.00905	CbGeAlD
Guanidine—KCNQ2—testis—hematologic cancer	0.000905	0.0089	CbGeAlD
Guanidine—KCNQ5—lymph node—hematologic cancer	0.000888	0.00873	CbGeAlD
Guanidine—KCNQ1—blood—hematologic cancer	0.000874	0.0086	CbGeAlD
Guanidine—KCND2—testis—hematologic cancer	0.000857	0.00842	CbGeAlD
Guanidine—KCNQ1—bone marrow—hematologic cancer	0.000846	0.00832	CbGeAlD
Guanidine—KCND3—lung—hematologic cancer	0.000791	0.00778	CbGeAlD
Guanidine—KCNQ1—lung—hematologic cancer	0.000766	0.00754	CbGeAlD
Guanidine—KCND3—testis—hematologic cancer	0.000747	0.00734	CbGeAlD
Guanidine—KCNA5—lymph node—hematologic cancer	0.000728	0.00716	CbGeAlD
Guanidine—KCNQ1—testis—hematologic cancer	0.000723	0.00711	CbGeAlD
Guanidine—KCNS3—lymph node—hematologic cancer	0.000712	0.00701	CbGeAlD
Guanidine—ALDH2—gonad—hematologic cancer	0.000699	0.00688	CbGeAlD
Guanidine—RNASE1—lymph node—hematologic cancer	0.000692	0.0068	CbGeAlD
Guanidine—GAMT—lymph node—hematologic cancer	0.000673	0.00662	CbGeAlD
Guanidine—SLC22A3—hematopoietic system—hematologic cancer	0.000654	0.00643	CbGeAlD
Guanidine—SLC22A8—hematopoietic system—hematologic cancer	0.000629	0.00619	CbGeAlD
Guanidine—ALDH2—blood—hematologic cancer	0.000609	0.00599	CbGeAlD
Guanidine—ALDH2—bone marrow—hematologic cancer	0.00059	0.0058	CbGeAlD
Guanidine—GAMT—Podofilox—Etoposide—hematologic cancer	0.000578	0.131	CbGdCrCtD
Guanidine—KCND3—lymph node—hematologic cancer	0.000541	0.00532	CbGeAlD
Guanidine—ALDH2—lung—hematologic cancer	0.000534	0.00525	CbGeAlD
Guanidine—KCNQ1—lymph node—hematologic cancer	0.000524	0.00516	CbGeAlD
Guanidine—ALDH2—testis—hematologic cancer	0.000504	0.00496	CbGeAlD
Guanidine—KCNH2—hematopoietic system—hematologic cancer	0.000503	0.00495	CbGeAlD
Guanidine—GAMT—Vinblastine—Vinorelbine—hematologic cancer	0.000497	0.113	CbGdCrCtD
Guanidine—SLC22A3—gonad—hematologic cancer	0.000497	0.00489	CbGeAlD
Guanidine—SLC22A4—blood—hematologic cancer	0.000476	0.00468	CbGeAlD
Guanidine—SLC22A4—bone marrow—hematologic cancer	0.000461	0.00453	CbGeAlD
Guanidine—SLC22A1—blood—hematologic cancer	0.000453	0.00446	CbGeAlD
Guanidine—SLC22A4—lung—hematologic cancer	0.000417	0.0041	CbGeAlD
Guanidine—SLC22A8—blood—hematologic cancer	0.000417	0.0041	CbGeAlD
Guanidine—GAMT—Vinblastine—Vincristine—hematologic cancer	0.000398	0.0901	CbGdCrCtD
Guanidine—SLC22A3—lung—hematologic cancer	0.00038	0.00373	CbGeAlD
Guanidine—GAMT—Azacitidine—Pentostatin—hematologic cancer	0.000377	0.0855	CbGdCrCtD
Guanidine—ALDH2—lymph node—hematologic cancer	0.000365	0.00359	CbGeAlD
Guanidine—SLC22A3—testis—hematologic cancer	0.000358	0.00352	CbGeAlD
Guanidine—GAMT—Azacitidine—Clofarabine—hematologic cancer	0.000336	0.0762	CbGdCrCtD
Guanidine—KCNH2—blood—hematologic cancer	0.000333	0.00328	CbGeAlD
Guanidine—KCNH2—bone marrow—hematologic cancer	0.000323	0.00317	CbGeAlD
Guanidine—GAMT—Azacitidine—Nelarabine—hematologic cancer	0.000316	0.0716	CbGdCrCtD
Guanidine—SLC22A5—blood—hematologic cancer	0.000315	0.0031	CbGeAlD
Guanidine—SLC22A4—lymph node—hematologic cancer	0.000285	0.00281	CbGeAlD
Guanidine—SLC22A5—lung—hematologic cancer	0.000276	0.00272	CbGeAlD
Guanidine—KCNH2—testis—hematologic cancer	0.000276	0.00271	CbGeAlD
Guanidine—SLC22A5—testis—hematologic cancer	0.000261	0.00256	CbGeAlD
Guanidine—SLC22A3—lymph node—hematologic cancer	0.00026	0.00255	CbGeAlD
Guanidine—GAMT—Azacitidine—Fludarabine—hematologic cancer	0.000247	0.0559	CbGdCrCtD
Guanidine—GAMT—Azacitidine—Gemcitabine—hematologic cancer	0.000233	0.0528	CbGdCrCtD
Guanidine—GAMT—Azacitidine—Cytarabine—hematologic cancer	0.000233	0.0528	CbGdCrCtD
Guanidine—GAMT—Azacitidine—Cladribine—hematologic cancer	0.000227	0.0514	CbGdCrCtD
Guanidine—KCNH2—lymph node—hematologic cancer	0.0002	0.00197	CbGeAlD
Guanidine—SLC22A5—lymph node—hematologic cancer	0.000189	0.00186	CbGeAlD
Guanidine—Feeling abnormal—Alitretinoin—hematologic cancer	9.95e-05	0.000512	CcSEcCtD
Guanidine—Hyperhidrosis—Cisplatin—hematologic cancer	9.94e-05	0.000512	CcSEcCtD
Guanidine—Liver function test abnormal—Epirubicin—hematologic cancer	9.92e-05	0.000511	CcSEcCtD
Guanidine—Rash—Melphalan—hematologic cancer	9.91e-05	0.00051	CcSEcCtD
Guanidine—Paraesthesia—Gemcitabine—hematologic cancer	9.91e-05	0.00051	CcSEcCtD
Guanidine—Dermatitis—Melphalan—hematologic cancer	9.9e-05	0.00051	CcSEcCtD
Guanidine—Decreased appetite—Mitoxantrone—hematologic cancer	9.85e-05	0.000507	CcSEcCtD
Guanidine—Decreased appetite—Irinotecan—hematologic cancer	9.85e-05	0.000507	CcSEcCtD
Guanidine—Feeling abnormal—Ifosfamide—hematologic cancer	9.83e-05	0.000506	CcSEcCtD
Guanidine—Nausea—Vinblastine—hematologic cancer	9.82e-05	0.000505	CcSEcCtD
Guanidine—Anorexia—Cisplatin—hematologic cancer	9.8e-05	0.000505	CcSEcCtD
Guanidine—Affect lability—Doxorubicin—hematologic cancer	9.79e-05	0.000504	CcSEcCtD
Guanidine—Rash—Lenalidomide—hematologic cancer	9.64e-05	0.000496	CcSEcCtD
Guanidine—Body temperature increased—Carmustine—hematologic cancer	9.63e-05	0.000496	CcSEcCtD
Guanidine—Abdominal pain—Carmustine—hematologic cancer	9.63e-05	0.000496	CcSEcCtD
Guanidine—Dermatitis—Lenalidomide—hematologic cancer	9.63e-05	0.000496	CcSEcCtD
Guanidine—Diarrhoea—Bortezomib—hematologic cancer	9.62e-05	0.000495	CcSEcCtD
Guanidine—Hypotension—Cisplatin—hematologic cancer	9.61e-05	0.000495	CcSEcCtD
Guanidine—Decreased appetite—Gemcitabine—hematologic cancer	9.59e-05	0.000494	CcSEcCtD
Guanidine—Abdominal pain—Alitretinoin—hematologic cancer	9.54e-05	0.000491	CcSEcCtD
Guanidine—Body temperature increased—Alitretinoin—hematologic cancer	9.54e-05	0.000491	CcSEcCtD
Guanidine—Rash—Hydroxyurea—hematologic cancer	9.5e-05	0.000489	CcSEcCtD
Guanidine—Confusional state—Etoposide—hematologic cancer	9.5e-05	0.000489	CcSEcCtD
Guanidine—Dermatitis—Hydroxyurea—hematologic cancer	9.49e-05	0.000489	CcSEcCtD
Guanidine—Hallucination—Prednisone—hematologic cancer	9.46e-05	0.000487	CcSEcCtD
Guanidine—Abdominal pain—Ifosfamide—hematologic cancer	9.43e-05	0.000485	CcSEcCtD
Guanidine—Body temperature increased—Ifosfamide—hematologic cancer	9.43e-05	0.000485	CcSEcCtD
Guanidine—Mood swings—Doxorubicin—hematologic cancer	9.42e-05	0.000485	CcSEcCtD
Guanidine—Diarrhoea—Vinorelbine—hematologic cancer	9.4e-05	0.000484	CcSEcCtD
Guanidine—Ataxia—Doxorubicin—hematologic cancer	9.35e-05	0.000481	CcSEcCtD
Guanidine—Nausea—Melphalan—hematologic cancer	9.34e-05	0.000481	CcSEcCtD
Guanidine—Feeling abnormal—Irinotecan—hematologic cancer	9.33e-05	0.00048	CcSEcCtD
Guanidine—Feeling abnormal—Mitoxantrone—hematologic cancer	9.33e-05	0.00048	CcSEcCtD
Guanidine—Dizziness—Bortezomib—hematologic cancer	9.3e-05	0.000479	CcSEcCtD
Guanidine—Paraesthesia—Cisplatin—hematologic cancer	9.23e-05	0.000475	CcSEcCtD
Guanidine—Thrombocytopenia—Etoposide—hematologic cancer	9.22e-05	0.000475	CcSEcCtD
Guanidine—Tachycardia—Etoposide—hematologic cancer	9.19e-05	0.000473	CcSEcCtD
Guanidine—Abdominal pain—Vincristine—hematologic cancer	9.19e-05	0.000473	CcSEcCtD
Guanidine—Body temperature increased—Vincristine—hematologic cancer	9.19e-05	0.000473	CcSEcCtD
Guanidine—Liver function test abnormal—Doxorubicin—hematologic cancer	9.18e-05	0.000473	CcSEcCtD
Guanidine—Hyperhidrosis—Etoposide—hematologic cancer	9.11e-05	0.000469	CcSEcCtD
Guanidine—Feeling abnormal—Gemcitabine—hematologic cancer	9.09e-05	0.000468	CcSEcCtD
Guanidine—Dizziness—Vinorelbine—hematologic cancer	9.08e-05	0.000468	CcSEcCtD
Guanidine—Nausea—Lenalidomide—hematologic cancer	9.08e-05	0.000467	CcSEcCtD
Guanidine—Tachycardia—Prednisolone—hematologic cancer	9.07e-05	0.000467	CcSEcCtD
Guanidine—Hyperhidrosis—Prednisolone—hematologic cancer	8.98e-05	0.000462	CcSEcCtD
Guanidine—Anorexia—Etoposide—hematologic cancer	8.98e-05	0.000462	CcSEcCtD
Guanidine—Diarrhoea—Thiotepa—hematologic cancer	8.97e-05	0.000462	CcSEcCtD
Guanidine—Abdominal pain—Mitoxantrone—hematologic cancer	8.95e-05	0.000461	CcSEcCtD
Guanidine—Abdominal pain—Irinotecan—hematologic cancer	8.95e-05	0.000461	CcSEcCtD
Guanidine—Body temperature increased—Mitoxantrone—hematologic cancer	8.95e-05	0.000461	CcSEcCtD
Guanidine—Body temperature increased—Irinotecan—hematologic cancer	8.95e-05	0.000461	CcSEcCtD
Guanidine—Nausea—Hydroxyurea—hematologic cancer	8.95e-05	0.000461	CcSEcCtD
Guanidine—Decreased appetite—Cisplatin—hematologic cancer	8.94e-05	0.00046	CcSEcCtD
Guanidine—Rash—Bortezomib—hematologic cancer	8.87e-05	0.000457	CcSEcCtD
Guanidine—Dermatitis—Bortezomib—hematologic cancer	8.86e-05	0.000456	CcSEcCtD
Guanidine—Flushing—Prednisone—hematologic cancer	8.82e-05	0.000454	CcSEcCtD
Guanidine—Hypotension—Etoposide—hematologic cancer	8.8e-05	0.000453	CcSEcCtD
Guanidine—Rash—Bleomycin—hematologic cancer	8.8e-05	0.000453	CcSEcCtD
Guanidine—Dermatitis—Bleomycin—hematologic cancer	8.79e-05	0.000453	CcSEcCtD
Guanidine—Body temperature increased—Gemcitabine—hematologic cancer	8.72e-05	0.000449	CcSEcCtD
Guanidine—Dry mouth—Triamcinolone—hematologic cancer	8.72e-05	0.000449	CcSEcCtD
Guanidine—Diarrhoea—Thalidomide—hematologic cancer	8.68e-05	0.000447	CcSEcCtD
Guanidine—Dizziness—Thiotepa—hematologic cancer	8.67e-05	0.000446	CcSEcCtD
Guanidine—Rash—Vinorelbine—hematologic cancer	8.66e-05	0.000446	CcSEcCtD
Guanidine—Dermatitis—Vinorelbine—hematologic cancer	8.65e-05	0.000445	CcSEcCtD
Guanidine—Sweating—Methotrexate—hematologic cancer	8.48e-05	0.000437	CcSEcCtD
Guanidine—Feeling abnormal—Cisplatin—hematologic cancer	8.47e-05	0.000436	CcSEcCtD
Guanidine—Paraesthesia—Etoposide—hematologic cancer	8.46e-05	0.000436	CcSEcCtD
Guanidine—Dizziness—Thalidomide—hematologic cancer	8.39e-05	0.000432	CcSEcCtD
Guanidine—Nausea—Bortezomib—hematologic cancer	8.35e-05	0.00043	CcSEcCtD
Guanidine—Paraesthesia—Prednisolone—hematologic cancer	8.34e-05	0.00043	CcSEcCtD
Guanidine—Tachycardia—Triamcinolone—hematologic cancer	8.34e-05	0.000429	CcSEcCtD
Guanidine—Diarrhoea—Carmustine—hematologic cancer	8.34e-05	0.000429	CcSEcCtD
Guanidine—Nausea—Bleomycin—hematologic cancer	8.29e-05	0.000427	CcSEcCtD
Guanidine—Rash—Thiotepa—hematologic cancer	8.27e-05	0.000426	CcSEcCtD
Guanidine—Dermatitis—Thiotepa—hematologic cancer	8.26e-05	0.000425	CcSEcCtD
Guanidine—Hyperhidrosis—Triamcinolone—hematologic cancer	8.26e-05	0.000425	CcSEcCtD
Guanidine—Diarrhoea—Alitretinoin—hematologic cancer	8.26e-05	0.000425	CcSEcCtD
Guanidine—Decreased appetite—Etoposide—hematologic cancer	8.19e-05	0.000422	CcSEcCtD
Guanidine—Diarrhoea—Ifosfamide—hematologic cancer	8.16e-05	0.00042	CcSEcCtD
Guanidine—Nausea—Vinorelbine—hematologic cancer	8.16e-05	0.00042	CcSEcCtD
Guanidine—Body temperature increased—Cisplatin—hematologic cancer	8.13e-05	0.000419	CcSEcCtD
Guanidine—Dizziness—Carmustine—hematologic cancer	8.06e-05	0.000415	CcSEcCtD
Guanidine—Rash—Thalidomide—hematologic cancer	8e-05	0.000412	CcSEcCtD
Guanidine—Dermatitis—Thalidomide—hematologic cancer	7.99e-05	0.000411	CcSEcCtD
Guanidine—Dizziness—Alitretinoin—hematologic cancer	7.98e-05	0.000411	CcSEcCtD
Guanidine—Diarrhoea—Vincristine—hematologic cancer	7.96e-05	0.00041	CcSEcCtD
Guanidine—Sweating—Epirubicin—hematologic cancer	7.94e-05	0.000409	CcSEcCtD
Guanidine—Dizziness—Ifosfamide—hematologic cancer	7.89e-05	0.000406	CcSEcCtD
Guanidine—Nausea—Thiotepa—hematologic cancer	7.79e-05	0.000401	CcSEcCtD
Guanidine—Feeling abnormal—Etoposide—hematologic cancer	7.76e-05	0.0004	CcSEcCtD
Guanidine—Diarrhoea—Irinotecan—hematologic cancer	7.75e-05	0.000399	CcSEcCtD
Guanidine—Diarrhoea—Mitoxantrone—hematologic cancer	7.75e-05	0.000399	CcSEcCtD
Guanidine—Dizziness—Vincristine—hematologic cancer	7.69e-05	0.000396	CcSEcCtD
Guanidine—Rash—Carmustine—hematologic cancer	7.68e-05	0.000395	CcSEcCtD
Guanidine—Dermatitis—Carmustine—hematologic cancer	7.67e-05	0.000395	CcSEcCtD
Guanidine—Paraesthesia—Triamcinolone—hematologic cancer	7.67e-05	0.000395	CcSEcCtD
Guanidine—Feeling abnormal—Prednisolone—hematologic cancer	7.66e-05	0.000394	CcSEcCtD
Guanidine—Anaemia—Prednisone—hematologic cancer	7.65e-05	0.000394	CcSEcCtD
Guanidine—Rash—Alitretinoin—hematologic cancer	7.61e-05	0.000392	CcSEcCtD
Guanidine—Dermatitis—Alitretinoin—hematologic cancer	7.6e-05	0.000391	CcSEcCtD
Guanidine—Thrombocytopenia—Betamethasone—hematologic cancer	7.59e-05	0.000391	CcSEcCtD
Guanidine—Thrombocytopenia—Dexamethasone—hematologic cancer	7.59e-05	0.000391	CcSEcCtD
Guanidine—Tachycardia—Betamethasone—hematologic cancer	7.57e-05	0.00039	CcSEcCtD
Guanidine—Tachycardia—Dexamethasone—hematologic cancer	7.57e-05	0.00039	CcSEcCtD
Guanidine—Diarrhoea—Gemcitabine—hematologic cancer	7.55e-05	0.000389	CcSEcCtD
Guanidine—Nausea—Thalidomide—hematologic cancer	7.53e-05	0.000388	CcSEcCtD
Guanidine—Rash—Ifosfamide—hematologic cancer	7.52e-05	0.000387	CcSEcCtD
Guanidine—Dermatitis—Ifosfamide—hematologic cancer	7.51e-05	0.000387	CcSEcCtD
Guanidine—Hyperhidrosis—Dexamethasone—hematologic cancer	7.5e-05	0.000386	CcSEcCtD
Guanidine—Hyperhidrosis—Betamethasone—hematologic cancer	7.5e-05	0.000386	CcSEcCtD
Guanidine—Dizziness—Irinotecan—hematologic cancer	7.49e-05	0.000386	CcSEcCtD
Guanidine—Abdominal pain—Etoposide—hematologic cancer	7.45e-05	0.000383	CcSEcCtD
Guanidine—Body temperature increased—Etoposide—hematologic cancer	7.45e-05	0.000383	CcSEcCtD
Guanidine—Anorexia—Betamethasone—hematologic cancer	7.39e-05	0.00038	CcSEcCtD
Guanidine—Anorexia—Dexamethasone—hematologic cancer	7.39e-05	0.00038	CcSEcCtD
Guanidine—Sweating—Doxorubicin—hematologic cancer	7.35e-05	0.000378	CcSEcCtD
Guanidine—Rash—Vincristine—hematologic cancer	7.33e-05	0.000378	CcSEcCtD
Guanidine—Dermatitis—Vincristine—hematologic cancer	7.33e-05	0.000377	CcSEcCtD
Guanidine—Hypotension—Dexamethasone—hematologic cancer	7.25e-05	0.000373	CcSEcCtD
Guanidine—Hypotension—Betamethasone—hematologic cancer	7.25e-05	0.000373	CcSEcCtD
Guanidine—Nausea—Carmustine—hematologic cancer	7.24e-05	0.000373	CcSEcCtD
Guanidine—Nausea—Alitretinoin—hematologic cancer	7.17e-05	0.000369	CcSEcCtD
Guanidine—Rash—Mitoxantrone—hematologic cancer	7.14e-05	0.000368	CcSEcCtD
Guanidine—Rash—Irinotecan—hematologic cancer	7.14e-05	0.000368	CcSEcCtD
Guanidine—Dermatitis—Irinotecan—hematologic cancer	7.13e-05	0.000367	CcSEcCtD
Guanidine—Dermatitis—Mitoxantrone—hematologic cancer	7.13e-05	0.000367	CcSEcCtD
Guanidine—Nausea—Ifosfamide—hematologic cancer	7.09e-05	0.000365	CcSEcCtD
Guanidine—Feeling abnormal—Triamcinolone—hematologic cancer	7.04e-05	0.000363	CcSEcCtD
Guanidine—Diarrhoea—Cisplatin—hematologic cancer	7.04e-05	0.000362	CcSEcCtD
Guanidine—Paraesthesia—Dexamethasone—hematologic cancer	6.96e-05	0.000358	CcSEcCtD
Guanidine—Paraesthesia—Betamethasone—hematologic cancer	6.96e-05	0.000358	CcSEcCtD
Guanidine—Rash—Gemcitabine—hematologic cancer	6.96e-05	0.000358	CcSEcCtD
Guanidine—Dermatitis—Gemcitabine—hematologic cancer	6.95e-05	0.000358	CcSEcCtD
Guanidine—Nausea—Vincristine—hematologic cancer	6.91e-05	0.000356	CcSEcCtD
Guanidine—Flushing—Epirubicin—hematologic cancer	6.9e-05	0.000355	CcSEcCtD
Guanidine—Body temperature increased—Triamcinolone—hematologic cancer	6.76e-05	0.000348	CcSEcCtD
Guanidine—Decreased appetite—Betamethasone—hematologic cancer	6.74e-05	0.000347	CcSEcCtD
Guanidine—Decreased appetite—Dexamethasone—hematologic cancer	6.74e-05	0.000347	CcSEcCtD
Guanidine—Nausea—Mitoxantrone—hematologic cancer	6.73e-05	0.000346	CcSEcCtD
Guanidine—Nausea—Irinotecan—hematologic cancer	6.73e-05	0.000346	CcSEcCtD
Guanidine—Tachycardia—Prednisone—hematologic cancer	6.59e-05	0.000339	CcSEcCtD
Guanidine—Nausea—Gemcitabine—hematologic cancer	6.55e-05	0.000337	CcSEcCtD
Guanidine—Hyperhidrosis—Prednisone—hematologic cancer	6.53e-05	0.000336	CcSEcCtD
Guanidine—Rash—Cisplatin—hematologic cancer	6.48e-05	0.000334	CcSEcCtD
Guanidine—Dermatitis—Cisplatin—hematologic cancer	6.48e-05	0.000333	CcSEcCtD
Guanidine—Diarrhoea—Etoposide—hematologic cancer	6.45e-05	0.000332	CcSEcCtD
Guanidine—Anorexia—Prednisone—hematologic cancer	6.44e-05	0.000331	CcSEcCtD
Guanidine—Anaemia—Methotrexate—hematologic cancer	6.39e-05	0.000329	CcSEcCtD
Guanidine—Feeling abnormal—Betamethasone—hematologic cancer	6.39e-05	0.000329	CcSEcCtD
Guanidine—Feeling abnormal—Dexamethasone—hematologic cancer	6.39e-05	0.000329	CcSEcCtD
Guanidine—Flushing—Doxorubicin—hematologic cancer	6.38e-05	0.000329	CcSEcCtD
Guanidine—Tension—Epirubicin—hematologic cancer	6.35e-05	0.000327	CcSEcCtD
Guanidine—Nervousness—Epirubicin—hematologic cancer	6.28e-05	0.000324	CcSEcCtD
Guanidine—Dizziness—Etoposide—hematologic cancer	6.23e-05	0.000321	CcSEcCtD
Guanidine—Leukopenia—Methotrexate—hematologic cancer	6.19e-05	0.000319	CcSEcCtD
Guanidine—Dizziness—Prednisolone—hematologic cancer	6.14e-05	0.000316	CcSEcCtD
Guanidine—Abdominal pain—Betamethasone—hematologic cancer	6.13e-05	0.000316	CcSEcCtD
Guanidine—Body temperature increased—Betamethasone—hematologic cancer	6.13e-05	0.000316	CcSEcCtD
Guanidine—Body temperature increased—Dexamethasone—hematologic cancer	6.13e-05	0.000316	CcSEcCtD
Guanidine—Abdominal pain—Dexamethasone—hematologic cancer	6.13e-05	0.000316	CcSEcCtD
Guanidine—Nausea—Cisplatin—hematologic cancer	6.11e-05	0.000314	CcSEcCtD
Guanidine—Paraesthesia—Prednisone—hematologic cancer	6.06e-05	0.000312	CcSEcCtD
Guanidine—Anaemia—Epirubicin—hematologic cancer	5.98e-05	0.000308	CcSEcCtD
Guanidine—Rash—Etoposide—hematologic cancer	5.94e-05	0.000306	CcSEcCtD
Guanidine—Dermatitis—Etoposide—hematologic cancer	5.93e-05	0.000306	CcSEcCtD
Guanidine—Tension—Doxorubicin—hematologic cancer	5.88e-05	0.000302	CcSEcCtD
Guanidine—Decreased appetite—Prednisone—hematologic cancer	5.87e-05	0.000302	CcSEcCtD
Guanidine—Rash—Prednisolone—hematologic cancer	5.86e-05	0.000302	CcSEcCtD
Guanidine—Dermatitis—Prednisolone—hematologic cancer	5.85e-05	0.000301	CcSEcCtD
Guanidine—Nervousness—Doxorubicin—hematologic cancer	5.82e-05	0.000299	CcSEcCtD
Guanidine—Leukopenia—Epirubicin—hematologic cancer	5.79e-05	0.000298	CcSEcCtD
Guanidine—Palpitations—Epirubicin—hematologic cancer	5.72e-05	0.000294	CcSEcCtD
Guanidine—Confusional state—Methotrexate—hematologic cancer	5.69e-05	0.000293	CcSEcCtD
Guanidine—Dizziness—Triamcinolone—hematologic cancer	5.65e-05	0.000291	CcSEcCtD
Guanidine—Nausea—Etoposide—hematologic cancer	5.6e-05	0.000288	CcSEcCtD
Guanidine—Feeling abnormal—Prednisone—hematologic cancer	5.56e-05	0.000286	CcSEcCtD
Guanidine—Anaemia—Doxorubicin—hematologic cancer	5.53e-05	0.000285	CcSEcCtD
Guanidine—Thrombocytopenia—Methotrexate—hematologic cancer	5.53e-05	0.000284	CcSEcCtD
Guanidine—Nausea—Prednisolone—hematologic cancer	5.52e-05	0.000284	CcSEcCtD
Guanidine—Hyperhidrosis—Methotrexate—hematologic cancer	5.46e-05	0.000281	CcSEcCtD
Guanidine—Rash—Triamcinolone—hematologic cancer	5.39e-05	0.000277	CcSEcCtD
Guanidine—Dry mouth—Epirubicin—hematologic cancer	5.39e-05	0.000277	CcSEcCtD
Guanidine—Dermatitis—Triamcinolone—hematologic cancer	5.38e-05	0.000277	CcSEcCtD
Guanidine—Anorexia—Methotrexate—hematologic cancer	5.38e-05	0.000277	CcSEcCtD
Guanidine—Leukopenia—Doxorubicin—hematologic cancer	5.36e-05	0.000276	CcSEcCtD
Guanidine—Body temperature increased—Prednisone—hematologic cancer	5.34e-05	0.000275	CcSEcCtD
Guanidine—Abdominal pain—Prednisone—hematologic cancer	5.34e-05	0.000275	CcSEcCtD
Guanidine—Confusional state—Epirubicin—hematologic cancer	5.32e-05	0.000274	CcSEcCtD
Guanidine—Diarrhoea—Dexamethasone—hematologic cancer	5.31e-05	0.000273	CcSEcCtD
Guanidine—Diarrhoea—Betamethasone—hematologic cancer	5.31e-05	0.000273	CcSEcCtD
Guanidine—Palpitations—Doxorubicin—hematologic cancer	5.29e-05	0.000272	CcSEcCtD
Guanidine—Hypotension—Methotrexate—hematologic cancer	5.27e-05	0.000271	CcSEcCtD
Guanidine—Thrombocytopenia—Epirubicin—hematologic cancer	5.17e-05	0.000266	CcSEcCtD
Guanidine—Tachycardia—Epirubicin—hematologic cancer	5.15e-05	0.000265	CcSEcCtD
Guanidine—Dizziness—Betamethasone—hematologic cancer	5.13e-05	0.000264	CcSEcCtD
Guanidine—Dizziness—Dexamethasone—hematologic cancer	5.13e-05	0.000264	CcSEcCtD
Guanidine—Hyperhidrosis—Epirubicin—hematologic cancer	5.11e-05	0.000263	CcSEcCtD
Guanidine—Nausea—Triamcinolone—hematologic cancer	5.08e-05	0.000261	CcSEcCtD
Guanidine—Paraesthesia—Methotrexate—hematologic cancer	5.07e-05	0.000261	CcSEcCtD
Guanidine—Anorexia—Epirubicin—hematologic cancer	5.03e-05	0.000259	CcSEcCtD
Guanidine—Dry mouth—Doxorubicin—hematologic cancer	4.99e-05	0.000257	CcSEcCtD
Guanidine—Hypotension—Epirubicin—hematologic cancer	4.93e-05	0.000254	CcSEcCtD
Guanidine—Confusional state—Doxorubicin—hematologic cancer	4.93e-05	0.000254	CcSEcCtD
Guanidine—Decreased appetite—Methotrexate—hematologic cancer	4.91e-05	0.000253	CcSEcCtD
Guanidine—Rash—Dexamethasone—hematologic cancer	4.89e-05	0.000252	CcSEcCtD
Guanidine—Rash—Betamethasone—hematologic cancer	4.89e-05	0.000252	CcSEcCtD
Guanidine—Dermatitis—Dexamethasone—hematologic cancer	4.88e-05	0.000251	CcSEcCtD
Guanidine—Dermatitis—Betamethasone—hematologic cancer	4.88e-05	0.000251	CcSEcCtD
Guanidine—Thrombocytopenia—Doxorubicin—hematologic cancer	4.78e-05	0.000246	CcSEcCtD
Guanidine—Tachycardia—Doxorubicin—hematologic cancer	4.77e-05	0.000246	CcSEcCtD
Guanidine—Paraesthesia—Epirubicin—hematologic cancer	4.74e-05	0.000244	CcSEcCtD
Guanidine—Hyperhidrosis—Doxorubicin—hematologic cancer	4.72e-05	0.000243	CcSEcCtD
Guanidine—Anorexia—Doxorubicin—hematologic cancer	4.66e-05	0.00024	CcSEcCtD
Guanidine—Feeling abnormal—Methotrexate—hematologic cancer	4.65e-05	0.000239	CcSEcCtD
Guanidine—Diarrhoea—Prednisone—hematologic cancer	4.62e-05	0.000238	CcSEcCtD
Guanidine—Nausea—Dexamethasone—hematologic cancer	4.61e-05	0.000237	CcSEcCtD
Guanidine—Nausea—Betamethasone—hematologic cancer	4.61e-05	0.000237	CcSEcCtD
Guanidine—Decreased appetite—Epirubicin—hematologic cancer	4.59e-05	0.000236	CcSEcCtD
Guanidine—Hypotension—Doxorubicin—hematologic cancer	4.57e-05	0.000235	CcSEcCtD
Guanidine—Dizziness—Prednisone—hematologic cancer	4.47e-05	0.00023	CcSEcCtD
Guanidine—Body temperature increased—Methotrexate—hematologic cancer	4.46e-05	0.00023	CcSEcCtD
Guanidine—Abdominal pain—Methotrexate—hematologic cancer	4.46e-05	0.00023	CcSEcCtD
Guanidine—Paraesthesia—Doxorubicin—hematologic cancer	4.39e-05	0.000226	CcSEcCtD
Guanidine—Feeling abnormal—Epirubicin—hematologic cancer	4.35e-05	0.000224	CcSEcCtD
Guanidine—Rash—Prednisone—hematologic cancer	4.26e-05	0.000219	CcSEcCtD
Guanidine—Dermatitis—Prednisone—hematologic cancer	4.25e-05	0.000219	CcSEcCtD
Guanidine—Decreased appetite—Doxorubicin—hematologic cancer	4.25e-05	0.000219	CcSEcCtD
Guanidine—Abdominal pain—Epirubicin—hematologic cancer	4.17e-05	0.000215	CcSEcCtD
Guanidine—Body temperature increased—Epirubicin—hematologic cancer	4.17e-05	0.000215	CcSEcCtD
Guanidine—Feeling abnormal—Doxorubicin—hematologic cancer	4.03e-05	0.000207	CcSEcCtD
Guanidine—Nausea—Prednisone—hematologic cancer	4.01e-05	0.000206	CcSEcCtD
Guanidine—Body temperature increased—Doxorubicin—hematologic cancer	3.86e-05	0.000199	CcSEcCtD
Guanidine—Abdominal pain—Doxorubicin—hematologic cancer	3.86e-05	0.000199	CcSEcCtD
Guanidine—Diarrhoea—Methotrexate—hematologic cancer	3.86e-05	0.000199	CcSEcCtD
Guanidine—Dizziness—Methotrexate—hematologic cancer	3.73e-05	0.000192	CcSEcCtD
Guanidine—Diarrhoea—Epirubicin—hematologic cancer	3.61e-05	0.000186	CcSEcCtD
Guanidine—Rash—Methotrexate—hematologic cancer	3.56e-05	0.000183	CcSEcCtD
Guanidine—Dermatitis—Methotrexate—hematologic cancer	3.55e-05	0.000183	CcSEcCtD
Guanidine—Dizziness—Epirubicin—hematologic cancer	3.49e-05	0.00018	CcSEcCtD
Guanidine—Nausea—Methotrexate—hematologic cancer	3.35e-05	0.000173	CcSEcCtD
Guanidine—Diarrhoea—Doxorubicin—hematologic cancer	3.34e-05	0.000172	CcSEcCtD
Guanidine—Rash—Epirubicin—hematologic cancer	3.33e-05	0.000171	CcSEcCtD
Guanidine—Dermatitis—Epirubicin—hematologic cancer	3.33e-05	0.000171	CcSEcCtD
Guanidine—Dizziness—Doxorubicin—hematologic cancer	3.23e-05	0.000166	CcSEcCtD
Guanidine—Nausea—Epirubicin—hematologic cancer	3.14e-05	0.000161	CcSEcCtD
Guanidine—Rash—Doxorubicin—hematologic cancer	3.08e-05	0.000159	CcSEcCtD
Guanidine—Dermatitis—Doxorubicin—hematologic cancer	3.08e-05	0.000158	CcSEcCtD
Guanidine—Nausea—Doxorubicin—hematologic cancer	2.9e-05	0.000149	CcSEcCtD
Guanidine—ALDH2—Metabolism—CYCS—hematologic cancer	1.15e-05	8.97e-05	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—CREBBP—hematologic cancer	1.15e-05	8.95e-05	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—CREBBP—hematologic cancer	1.15e-05	8.95e-05	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—CREBBP—hematologic cancer	1.15e-05	8.95e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—NCOR2—hematologic cancer	1.14e-05	8.92e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—HSP90AA1—hematologic cancer	1.14e-05	8.91e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmission across Chemical Synapses—CREB1—hematologic cancer	1.14e-05	8.89e-05	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—MAPK3—hematologic cancer	1.13e-05	8.85e-05	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—MAPK3—hematologic cancer	1.13e-05	8.85e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CDA—hematologic cancer	1.13e-05	8.8e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.13e-05	8.79e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmission across Chemical Synapses—BRAF—hematologic cancer	1.13e-05	8.78e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.12e-05	8.73e-05	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—TGFB1—hematologic cancer	1.1e-05	8.58e-05	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—TGFB1—hematologic cancer	1.1e-05	8.58e-05	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—AKT1—hematologic cancer	1.1e-05	8.57e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.1e-05	8.55e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—IDH1—hematologic cancer	1.09e-05	8.5e-05	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PIK3CD—hematologic cancer	1.09e-05	8.49e-05	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PIK3CD—hematologic cancer	1.09e-05	8.49e-05	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PIK3CD—hematologic cancer	1.09e-05	8.49e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—CREBBP—hematologic cancer	1.09e-05	8.48e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PC—hematologic cancer	1.09e-05	8.47e-05	CbGpPWpGaD
Guanidine—GAMT—Metabolism—PIK3CB—hematologic cancer	1.08e-05	8.46e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—ABCC3—hematologic cancer	1.08e-05	8.4e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—TXN—hematologic cancer	1.08e-05	8.4e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—GSTO1—hematologic cancer	1.08e-05	8.4e-05	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—ALB—hematologic cancer	1.07e-05	8.38e-05	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—ALB—hematologic cancer	1.07e-05	8.38e-05	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—ALB—hematologic cancer	1.07e-05	8.38e-05	CbGpPWpGaD
Guanidine—SLC22A8—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.05e-05	8.23e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—SPHK1—hematologic cancer	1.05e-05	8.22e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CDA—hematologic cancer	1.05e-05	8.2e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GBA—hematologic cancer	1.05e-05	8.18e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—SLC35B2—hematologic cancer	1.05e-05	8.18e-05	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.05e-05	8.18e-05	CbGpPWpGaD
Guanidine—KCNH2—SIDS Susceptibility Pathways—IL6—hematologic cancer	1.04e-05	8.1e-05	CbGpPWpGaD
Guanidine—SLC22A4—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.04e-05	8.09e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PIK3CD—hematologic cancer	1.03e-05	8.04e-05	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—TNF—hematologic cancer	1.03e-05	8.02e-05	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—TNF—hematologic cancer	1.03e-05	8.02e-05	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PIK3R1—hematologic cancer	1.03e-05	8.01e-05	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PIK3R1—hematologic cancer	1.03e-05	8.01e-05	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PIK3R1—hematologic cancer	1.03e-05	8.01e-05	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—KRAS—hematologic cancer	1.02e-05	7.95e-05	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—KRAS—hematologic cancer	1.02e-05	7.95e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—ALB—hematologic cancer	1.02e-05	7.94e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—GSTP1—hematologic cancer	1.01e-05	7.9e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—UGT1A1—hematologic cancer	1.01e-05	7.9e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PC—hematologic cancer	1.01e-05	7.89e-05	CbGpPWpGaD
Guanidine—SLC22A2—Transmission across Chemical Synapses—MDM2—hematologic cancer	1.01e-05	7.89e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—SLC22A1—hematologic cancer	9.85e-06	7.69e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CRABP1—hematologic cancer	9.85e-06	7.69e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—SLC35B2—hematologic cancer	9.77e-06	7.62e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GBA—hematologic cancer	9.77e-06	7.62e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	9.77e-06	7.62e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PIK3R1—hematologic cancer	9.74e-06	7.6e-05	CbGpPWpGaD
Guanidine—SLC22A4—Transmembrane transport of small molecules—ALB—hematologic cancer	9.71e-06	7.57e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—ALOX5—hematologic cancer	9.6e-06	7.49e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—MTAP—hematologic cancer	9.59e-06	7.48e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—ABCB1—hematologic cancer	9.59e-06	7.48e-05	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PIK3CB—hematologic cancer	9.48e-06	7.4e-05	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PIK3CB—hematologic cancer	9.48e-06	7.4e-05	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PIK3CB—hematologic cancer	9.48e-06	7.4e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmission across Chemical Synapses—MDM2—hematologic cancer	9.43e-06	7.35e-05	CbGpPWpGaD
Guanidine—GAMT—Metabolism—PTEN—hematologic cancer	9.37e-06	7.31e-05	CbGpPWpGaD
Guanidine—SLC22A2—Neuronal System—CREB1—hematologic cancer	9.37e-06	7.31e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—GSTM1—hematologic cancer	9.31e-06	7.26e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—NCOR1—hematologic cancer	9.31e-06	7.26e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—NUP98—hematologic cancer	9.3e-06	7.25e-05	CbGpPWpGaD
Guanidine—SLC22A2—Neuronal System—BRAF—hematologic cancer	9.25e-06	7.22e-05	CbGpPWpGaD
Guanidine—SLC22A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	9.03e-06	7.05e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—NCOA3—hematologic cancer	9.03e-06	7.04e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—ADCY7—hematologic cancer	9.03e-06	7.04e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PIK3CB—hematologic cancer	8.99e-06	7.01e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—NUP214—hematologic cancer	8.96e-06	6.99e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—MTAP—hematologic cancer	8.94e-06	6.97e-05	CbGpPWpGaD
Guanidine—GAMT—Metabolism—EP300—hematologic cancer	8.94e-06	6.97e-05	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	8.8e-06	6.86e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—ABCG2—hematologic cancer	8.78e-06	6.85e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—MTR—hematologic cancer	8.78e-06	6.85e-05	CbGpPWpGaD
Guanidine—SLC22A1—Neuronal System—CREB1—hematologic cancer	8.73e-06	6.81e-05	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—HRAS—hematologic cancer	8.66e-06	6.76e-05	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—HRAS—hematologic cancer	8.66e-06	6.76e-05	CbGpPWpGaD
Guanidine—SLC22A1—Neuronal System—BRAF—hematologic cancer	8.62e-06	6.73e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—ENO2—hematologic cancer	8.61e-06	6.72e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—FHL2—hematologic cancer	8.55e-06	6.67e-05	CbGpPWpGaD
Guanidine—SLC22A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	8.42e-06	6.57e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—AGRN—hematologic cancer	8.38e-06	6.54e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—GSTT1—hematologic cancer	8.35e-06	6.52e-05	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—IL6—hematologic cancer	8.29e-06	6.47e-05	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—IL6—hematologic cancer	8.29e-06	6.47e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—MTHFR—hematologic cancer	8.23e-06	6.42e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	8.2e-06	6.4e-05	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PTEN—hematologic cancer	8.19e-06	6.39e-05	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PTEN—hematologic cancer	8.19e-06	6.39e-05	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PTEN—hematologic cancer	8.19e-06	6.39e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—SDC1—hematologic cancer	8.16e-06	6.37e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—FHL2—hematologic cancer	7.97e-06	6.22e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—HMMR—hematologic cancer	7.95e-06	6.2e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—IDH2—hematologic cancer	7.95e-06	6.2e-05	CbGpPWpGaD
Guanidine—SLC22A3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.82e-06	6.1e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—AGRN—hematologic cancer	7.81e-06	6.1e-05	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—EP300—hematologic cancer	7.81e-06	6.1e-05	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—EP300—hematologic cancer	7.81e-06	6.1e-05	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—EP300—hematologic cancer	7.81e-06	6.1e-05	CbGpPWpGaD
Guanidine—SLC22A5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.79e-06	6.08e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PTEN—hematologic cancer	7.77e-06	6.06e-05	CbGpPWpGaD
Guanidine—SLC22A2—Neuronal System—MDM2—hematologic cancer	7.75e-06	6.05e-05	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—AKT1—hematologic cancer	7.65e-06	5.97e-05	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—AKT1—hematologic cancer	7.65e-06	5.97e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ARNTL—hematologic cancer	7.47e-06	5.83e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—EP300—hematologic cancer	7.41e-06	5.78e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—IDH2—hematologic cancer	7.41e-06	5.78e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—HMMR—hematologic cancer	7.41e-06	5.78e-05	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.34e-06	5.73e-05	CbGpPWpGaD
Guanidine—SLC22A3—Transmembrane transport of small molecules—ALB—hematologic cancer	7.32e-06	5.71e-05	CbGpPWpGaD
Guanidine—SLC22A5—Transmembrane transport of small molecules—ALB—hematologic cancer	7.3e-06	5.69e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CA9—hematologic cancer	7.27e-06	5.67e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ACP5—hematologic cancer	7.27e-06	5.67e-05	CbGpPWpGaD
Guanidine—SLC22A1—Neuronal System—MDM2—hematologic cancer	7.22e-06	5.63e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—NCOR2—hematologic cancer	7.17e-06	5.6e-05	CbGpPWpGaD
Guanidine—SLC22A8—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.05e-06	5.5e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ARNTL—hematologic cancer	6.96e-06	5.43e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CD44—hematologic cancer	6.94e-06	5.42e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—NQO1—hematologic cancer	6.94e-06	5.42e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PIK3CG—hematologic cancer	6.91e-06	5.39e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	6.84e-06	5.34e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—IDH1—hematologic cancer	6.83e-06	5.33e-05	CbGpPWpGaD
Guanidine—KCNH2—Neuronal System—HRAS—hematologic cancer	6.81e-06	5.32e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CA9—hematologic cancer	6.77e-06	5.28e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ACP5—hematologic cancer	6.77e-06	5.28e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GSTO1—hematologic cancer	6.76e-06	5.27e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ABCC3—hematologic cancer	6.76e-06	5.27e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—TXN—hematologic cancer	6.76e-06	5.27e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—NCOR2—hematologic cancer	6.69e-06	5.22e-05	CbGpPWpGaD
Guanidine—GAMT—Metabolism—PIK3CA—hematologic cancer	6.61e-06	5.16e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—SPHK1—hematologic cancer	6.61e-06	5.16e-05	CbGpPWpGaD
Guanidine—SLC22A8—Transmembrane transport of small molecules—ALB—hematologic cancer	6.6e-06	5.15e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CYCS—hematologic cancer	6.57e-06	5.12e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—HSP90AA1—hematologic cancer	6.53e-06	5.09e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—CREBBP—hematologic cancer	6.41e-06	5e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—IDH1—hematologic cancer	6.37e-06	4.97e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—UGT1A1—hematologic cancer	6.35e-06	4.96e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—TXN—hematologic cancer	6.3e-06	4.91e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GSTO1—hematologic cancer	6.3e-06	4.91e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ABCC3—hematologic cancer	6.3e-06	4.91e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—SLC22A1—hematologic cancer	6.18e-06	4.82e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CRABP1—hematologic cancer	6.18e-06	4.82e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—SPHK1—hematologic cancer	6.16e-06	4.81e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PIK3CD—hematologic cancer	6.08e-06	4.74e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ALOX5—hematologic cancer	6.02e-06	4.7e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—ALB—hematologic cancer	6e-06	4.68e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—UGT1A1—hematologic cancer	5.92e-06	4.62e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—NUP98—hematologic cancer	5.83e-06	4.55e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—GSTP1—hematologic cancer	5.79e-06	4.52e-05	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PIK3CA—hematologic cancer	5.78e-06	4.51e-05	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PIK3CA—hematologic cancer	5.78e-06	4.51e-05	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PIK3CA—hematologic cancer	5.78e-06	4.51e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CRABP1—hematologic cancer	5.76e-06	4.49e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PIK3R1—hematologic cancer	5.74e-06	4.48e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ADCY7—hematologic cancer	5.66e-06	4.42e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—NCOA3—hematologic cancer	5.66e-06	4.42e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—NUP214—hematologic cancer	5.62e-06	4.39e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ALOX5—hematologic cancer	5.61e-06	4.38e-05	CbGpPWpGaD
Guanidine—SLC22A2—Transmission across Chemical Synapses—HRAS—hematologic cancer	5.55e-06	4.33e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—MTR—hematologic cancer	5.51e-06	4.3e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ABCG2—hematologic cancer	5.51e-06	4.3e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—ABCB1—hematologic cancer	5.48e-06	4.28e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PIK3CA—hematologic cancer	5.48e-06	4.27e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—NUP98—hematologic cancer	5.44e-06	4.24e-05	CbGpPWpGaD
Guanidine—GAMT—Metabolism—AKT1—hematologic cancer	5.4e-06	4.21e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ENO2—hematologic cancer	5.4e-06	4.21e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—GSTM1—hematologic cancer	5.32e-06	4.15e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—NCOR1—hematologic cancer	5.32e-06	4.15e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PIK3CB—hematologic cancer	5.3e-06	4.13e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ADCY7—hematologic cancer	5.28e-06	4.12e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—NCOA3—hematologic cancer	5.28e-06	4.12e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—NUP214—hematologic cancer	5.24e-06	4.09e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GSTT1—hematologic cancer	5.24e-06	4.09e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmission across Chemical Synapses—HRAS—hematologic cancer	5.17e-06	4.04e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—MTR—hematologic cancer	5.13e-06	4.01e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ABCG2—hematologic cancer	5.13e-06	4.01e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—SDC1—hematologic cancer	5.12e-06	3.99e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ENO2—hematologic cancer	5.03e-06	3.93e-05	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.9e-06	3.83e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GSTT1—hematologic cancer	4.88e-06	3.81e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—SDC1—hematologic cancer	4.77e-06	3.72e-05	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—AKT1—hematologic cancer	4.72e-06	3.68e-05	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—AKT1—hematologic cancer	4.72e-06	3.68e-05	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—AKT1—hematologic cancer	4.72e-06	3.68e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—MTHFR—hematologic cancer	4.7e-06	3.67e-05	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—ALB—hematologic cancer	4.59e-06	3.58e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PTEN—hematologic cancer	4.58e-06	3.57e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.57e-06	3.57e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—AKT1—hematologic cancer	4.48e-06	3.49e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—EP300—hematologic cancer	4.36e-06	3.41e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—NQO1—hematologic cancer	4.35e-06	3.4e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CD44—hematologic cancer	4.35e-06	3.4e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.28e-06	3.34e-05	CbGpPWpGaD
Guanidine—SLC22A2—Neuronal System—HRAS—hematologic cancer	4.25e-06	3.32e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CYCS—hematologic cancer	4.12e-06	3.21e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—HSP90AA1—hematologic cancer	4.09e-06	3.19e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—NQO1—hematologic cancer	4.06e-06	3.17e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CD44—hematologic cancer	4.06e-06	3.17e-05	CbGpPWpGaD
Guanidine—SLC22A1—Neuronal System—HRAS—hematologic cancer	3.96e-06	3.09e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PIK3CG—hematologic cancer	3.95e-06	3.08e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYCS—hematologic cancer	3.84e-06	3e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—HSP90AA1—hematologic cancer	3.82e-06	2.98e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CREBBP—hematologic cancer	3.66e-06	2.86e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GSTP1—hematologic cancer	3.63e-06	2.83e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PIK3CD—hematologic cancer	3.47e-06	2.71e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ABCB1—hematologic cancer	3.44e-06	2.68e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—ALB—hematologic cancer	3.43e-06	2.67e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GSTP1—hematologic cancer	3.38e-06	2.64e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GSTM1—hematologic cancer	3.34e-06	2.6e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—NCOR1—hematologic cancer	3.34e-06	2.6e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PIK3R1—hematologic cancer	3.28e-06	2.56e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PIK3CA—hematologic cancer	3.23e-06	2.52e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ABCB1—hematologic cancer	3.2e-06	2.5e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GSTM1—hematologic cancer	3.11e-06	2.43e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—NCOR1—hematologic cancer	3.11e-06	2.43e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PIK3CB—hematologic cancer	3.03e-06	2.36e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—MTHFR—hematologic cancer	2.95e-06	2.3e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—MTHFR—hematologic cancer	2.75e-06	2.14e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—AKT1—hematologic cancer	2.64e-06	2.06e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PTEN—hematologic cancer	2.62e-06	2.04e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—EP300—hematologic cancer	2.49e-06	1.95e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PIK3CG—hematologic cancer	2.48e-06	1.93e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PIK3CG—hematologic cancer	2.31e-06	1.8e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CREBBP—hematologic cancer	2.3e-06	1.79e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PIK3CD—hematologic cancer	2.18e-06	1.7e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ALB—hematologic cancer	2.15e-06	1.68e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CREBBP—hematologic cancer	2.14e-06	1.67e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PIK3R1—hematologic cancer	2.06e-06	1.6e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PIK3CD—hematologic cancer	2.03e-06	1.58e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ALB—hematologic cancer	2e-06	1.56e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PIK3R1—hematologic cancer	1.92e-06	1.5e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PIK3CB—hematologic cancer	1.9e-06	1.48e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PIK3CA—hematologic cancer	1.85e-06	1.44e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PIK3CB—hematologic cancer	1.77e-06	1.38e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PTEN—hematologic cancer	1.64e-06	1.28e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—EP300—hematologic cancer	1.56e-06	1.22e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PTEN—hematologic cancer	1.53e-06	1.19e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—AKT1—hematologic cancer	1.51e-06	1.18e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—EP300—hematologic cancer	1.46e-06	1.14e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PIK3CA—hematologic cancer	1.16e-06	9.03e-06	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PIK3CA—hematologic cancer	1.08e-06	8.42e-06	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—AKT1—hematologic cancer	9.45e-07	7.38e-06	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—AKT1—hematologic cancer	8.81e-07	6.88e-06	CbGpPWpGaD
